Zirn B - Search Results

1

Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.

Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, Mertens F, Graf N, Eilers M, Gessler M. Zirn B, et al. Int J Cancer. 2006 Apr 15;118(8):1954-62. doi: 10.1002/ijc.21564. Int J Cancer. 2006. PMID: 16287080

2

Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.

Zirn B, Wittmann S, Graf N, Gessler M. Zirn B, et al. Cancer Lett. 2005 Mar 18;220(1):115-20. doi: 10.1016/j.canlet.2004.08.001. Cancer Lett. 2005. PMID: 15737694

3

All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.

Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M. Zirn B, et al. Oncogene. 2005 Aug 4;24(33):5246-51. doi: 10.1038/sj.onc.1208725. Oncogene. 2005. PMID: 15897880

4

Target genes of the WNT/beta-catenin pathway in Wilms tumors.

Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M. Zirn B, et al. Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. doi: 10.1002/gcc.20319. Genes Chromosomes Cancer. 2006. PMID: 16575872

5

Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.

Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, Gessler M. Wittmann S, et al. Among authors: zirn b. Genes Chromosomes Cancer. 2007 Feb;46(2):163-70. doi: 10.1002/gcc.20397. Genes Chromosomes Cancer. 2007. PMID: 17099873

6

New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors.

Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, Graf N, Gessler M. Wittmann S, et al. Among authors: zirn b. Genes Chromosomes Cancer. 2008 May;47(5):386-95. doi: 10.1002/gcc.20544. Genes Chromosomes Cancer. 2008. PMID: 18260125

7

Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy.

Zirn B, Wittmann S, Gessler M. Zirn B, et al. Am J Kidney Dis. 2005 Jun;45(6):1100-4. doi: 10.1053/j.ajkd.2005.03.013. Am J Kidney Dis. 2005. PMID: 15957141

8

Novel TOR1A mutation p.Arg288Gln in early-onset dystonia (DYT1).

Zirn B, Grundmann K, Huppke P, Puthenparampil J, Wolburg H, Riess O, Müller U. Zirn B, et al. J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1327-30. doi: 10.1136/jnnp.2008.148270. Epub 2008 May 13. J Neurol Neurosurg Psychiatry. 2008. PMID: 18477710

9

Frequency of GCH1 deletions in Dopa-responsive dystonia.

Zirn B, Steinberger D, Troidl C, Brockmann K, von der Hagen M, Feiner C, Henke L, Müller U. Zirn B, et al. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):183-6. doi: 10.1136/jnnp.2007.128413. Epub 2007 Sep 26. J Neurol Neurosurg Psychiatry. 2008. PMID: 17898029

10

Utility of MLPA in deletion analysis of GCH1 in dopa-responsive dystonia.

Steinberger D, Trübenbach J, Zirn B, Leube B, Wildhardt G, Müller U. Steinberger D, et al. Among authors: zirn b. Neurogenetics. 2007 Jan;8(1):51-5. doi: 10.1007/s10048-006-0069-6. Epub 2006 Nov 17. Neurogenetics. 2007. PMID: 17111153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters